Elan Pharmaceuticals Licenses Ariadne’s Pathway Studio® With MedScan® Text Mining Module
ROCKVILLE, MD, November 29, 2007 – Ariadne announced today that Elan Pharmaceuticals Inc. has licensed its Pathway Studio software. Elan is biotechnology company focused on discovery and development of therapies for neurology and autoimmune diseases. They chose Pathway Studio for its advanced text-mining tools and powerful experimental data interpretation and pathway analysis capability.
Ariadne’s Pathway Studio includes the ResNet database of functional relationships that can be used for assembly of biological pathways, exploring signaling networks, and to interpret microarray experimental data. MedScan’s natural language processing technology enables customers to extend ResNet though extraction of pathway-related information from biomedical literature.
“Ariadne’s Pathway Studio, MedScan, and ResNet complement the tools already in use at Elan for pathway investigation and gene expression analysis”, commented Jim Miller, Principal Scientist at Elan Pharmaceuticals, “The MedScan module, in particular, gives a scientist the capability to quickly create pathways from the newest literature sources in a matter of minutes.
“Ariadne worked with several research groups at Elan to meet their common and unique requirements. Pathway Studio’s flexible support for multiple workflows and data types was a key factor in acceptance of the product across the company,” commented John Clouston, Senior Director of Sales at Ariadne.
For more information about Pathway Studio and MedScan Technology, please contact Ariadne at 240-453-6296, or visit www.ariadnegenomics.com.
About Ariadne
ARIADNE (www.ariadnegenomics.com) Pathway Studio software is used worldwide as a comprehensive solution for analysis and searching of pathways and molecular interaction information. Ariadne offers desktop and enterprise editions of Pathway Studio which are supported by several commercial and publicly available molecular interaction databases including ResNet Mammalian and ResNet Plant. Pathway Studio powered by MedScan Technology can be used to edit and enhance database content from the current literature and from experimental data.
